Several observations in our study, such as the presence of HPV16 DNA in cancers and dysplasias only, and the increased proliferation rate in p16INK4a-overexpressed tumor areas in HPV-positive cancers, suggest that HPV infection might play a role in a subset of ESCC patients. This evidence concerns the gene CDKN2A and cancer.